Delivery Order SPE2DR25D3014-SPE2DR26FP1FC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,924.52 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on December 3, 2025, with completion scheduled for December 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a direct fulfillment transaction under AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Multaq 400 mg tablets (60-count units) with a ceiling value of $5,337.74. This firm fixed-price delivery order is scheduled for completion by December 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively made with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a $3,081.81 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Multaq 400 mg tablets (60-count). This firm fixed price contract, with an ultimate completion date of November 5, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $2,962.26. This is a firm fixed-price delivery order with an ultimate completion date of November 13, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $3,059.76 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count packages) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this pharmaceutical delivery from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $8,071.55 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on December 2, 2025, with an ultimate completion date of December 3, 2025. This is a firm fixed-price, non-set-aside contract with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $6,351.04 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $11,244.20 on December 1, 2025, for the supply of Multaq 400 mg tablets (60 count). This non-set-aside, firm fixed-price delivery order is scheduled for completion by December 2, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement executed under the company's existing contract vehicle with DLA....
- The Defense Logistics Agency awarded a delivery order valued at $37,333.81 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on July 15, 2025, with an ultimate completion date of July 16, 2025. The contract utilizes firm fixed pricing and was competitively awarded without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $11,985.90. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order, with an ultimate completion date of August 13, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate...
- SPE2DR25D3014Indefinite Delivery Contract
- SPE2DR25D3014-SPE2DR26FP1FCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,290.92 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on December 3, 2025, with a completion date of December 4, 2025. The contract employs firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical delivery. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare systems, encompassing a broad range of medications, vaccines, medical devices, and specialized healthcare commodities. AmerisourceBergen's position as a major pharmaceutical distributor and critical vendor in the federal medical procurement space—particularly serving the Defense Health Agency and other government healthcare systems—demonstrates the company's established capability to fulfill federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 12/2/25 |